Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Lung cancer screening: the way forward.

Field JK, Duffy SW.

Br J Cancer. 2008 Aug 19;99(4):557-62. doi: 10.1038/sj.bjc.6604509. Epub 2008 Jul 29. Review.

2.

Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.

Goulart BH, Bensink ME, Mummy DG, Ramsey SD.

J Natl Compr Canc Netw. 2012 Feb;10(2):267-75. Review.

PMID:
22308519
3.

A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population?

Fu C, Liu Z, Zhu F, Li S, Jiang L.

Clin Respir J. 2016 May;10(3):333-41. doi: 10.1111/crj.12222. Epub 2014 Nov 26. Review.

PMID:
25307063
4.

Reviewing risks and benefits of low-dose computed tomography screening for lung cancer.

Chopra I, Chopra A, Bias TK.

Postgrad Med. 2016;128(2):254-61. doi: 10.1080/00325481.2016.1134023. Epub 2016 Jan 6. Review.

PMID:
26680693
5.

Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs.

Goulart BH, Ramsey SD.

Oncologist. 2013;18(8):941-6. doi: 10.1634/theoncologist.2013-0007. Epub 2013 Jul 19.

6.

Benefits and harms of CT screening for lung cancer: a systematic review.

Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, Byers T, Colditz GA, Gould MK, Jett JR, Sabichi AL, Smith-Bindman R, Wood DE, Qaseem A, Detterbeck FC.

JAMA. 2012 Jun 13;307(22):2418-29. doi: 10.1001/jama.2012.5521. Review. Erratum in: JAMA. 2013 Jun 5;309(21):2212. JAMA. 2012 Oct 3;308(13):1324.

7.

Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.

Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):344-53. doi: 10.1016/j.ijrobp.2014.06.013. Epub 2014 Aug 4.

PMID:
25104066
8.

Current estimate of costs of lung cancer screening in the United States.

Mauchley DC, Mitchell JD.

Thorac Surg Clin. 2015 May;25(2):205-15. doi: 10.1016/j.thorsurg.2014.12.005. Epub 2015 Mar 7. Review.

PMID:
25901564
9.

Lung cancer screening and management.

Jones GS, Baldwin DR.

Minerva Med. 2015 Dec;106(6):339-54. Epub 2015 Nov 25. Review.

PMID:
26605556
10.

Lung Cancer Screening With Low-Dose CT in the United States.

Eberth JM.

J Am Coll Radiol. 2015 Dec;12(12 Pt B):1395-402. doi: 10.1016/j.jacr.2015.09.016.

PMID:
26614885
11.

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.

Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, Brambilla G, Angeli E, Aranzulla G, Chiti A, Scorsetti M, Navarria P, Cavina R, Ciccarelli M, Roncalli M, Destro A, Bottoni E, Voulaz E, Errico V, Ferraroli G, Finocchiaro G, Toschi L, Santoro A, Alloisio M; DANTE Study Group.

Am J Respir Crit Care Med. 2015 May 15;191(10):1166-75. doi: 10.1164/rccm.201408-1475OC.

PMID:
25760561
12.

The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.

Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, Ayres J, Bain L, Thomas S, Godden D, Waugh N.

Health Technol Assess. 2006 Jan;10(3):iii-iv, ix-x, 1-90. Review.

13.

Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).

Blanchon T, Bréchot JM, Grenier PA, Ferretti GR, Lemarié E, Milleron B, Chagué D, Laurent F, Martinet Y, Beigelman-Aubry C, Blanchon F, Revel MP, Friard S, Rémy-Jardin M, Vasile M, Santelmo N, Lecalier A, Lefébure P, Moro-Sibilot D, Breton JL, Carette MF, Brambilla C, Fournel F, Kieffer A, Frija G, Flahault A; Dépiscan Group.

Lung Cancer. 2007 Oct;58(1):50-8. Epub 2007 Jul 12.

PMID:
17624475
14.

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team.

JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. Erratum in: JAMA Intern Med. 2014 May;174(5):828.

15.

Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.

Puggina A, Broumas A, Ricciardi W, Boccia S.

Eur J Public Health. 2016 Feb;26(1):168-75. doi: 10.1093/eurpub/ckv158. Epub 2015 Sep 14. Review.

PMID:
26370440
16.

[Screening for lung cancer in the Netherlands: the role of spiral CT scan].

van Klaveren RJ, Habbema JD, de Koning HJ, Oudkerk M, Damhuis RA, Hoogsteden HC.

Ned Tijdschr Geneeskd. 2001 Mar 17;145(11):521-6. Review. Dutch.

PMID:
11284285
17.

A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.

Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Errico V, Inzirillo F, Bottoni E, Voulaz E, Alloisio M, Destro A, Roncalli M, Santoro A, Ravasi G; DANTE Study Group.

Am J Respir Crit Care Med. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. Epub 2009 Jun 11.

PMID:
19520905
18.

Low-dose computed tomography screening for lung cancer: results of the first screening round.

Horeweg N, Nackaerts K, Oudkerk M, de Koning HJ.

J Comp Eff Res. 2013 Sep;2(5):433-6. doi: 10.2217/cer.13.57.

PMID:
24236740
19.

Update in screening of lung cancer.

Artinian V, Kvale PA.

Respirology. 2005 Nov;10(5):558-66. Review.

PMID:
16268907

Supplemental Content

Support Center